Interestingly, both voluntary and treadmill running regimens in AD rodent models have led to reduced tissue hallmarks of AD progression, such as Aβ40/42 levels and tau phosphorylation (Ryan and Kelly, 2016). The gene discussed is MAPT; the disease is Alzheimer disease.